Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe study record history now shows a new revision entry v3.5.5 and removes the earlier revision v3.5.4 from the list.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry v3.5.4 was added to the study record history. The previous revision v3.5.3 was removed from the listing.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe Record History now shows a new revision label, Revision: v3.5.3, replacing Revision: v3.5.2. This update represents a small page version update rather than changes to the trial content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe record history now includes a new revision entry v3.5.2 and removes v3.5.0 from the list.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded a new 'Study Status' entry on 2026-03-25 and version 9 on 2026-03-23. Deleted the 2025-05-29 entry.SummaryDifference0.4%

- Check72 days agoChange DetectedAdded revision: v3.5.0; removed revision: v3.4.3 from the record history.SummaryDifference0.1%

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.